Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)

被引:940
作者
Bunce, M
ONeill, CM
Barnardo, MCNM
Krausa, P
Browning, MJ
Morris, PJ
Welsh, KI
机构
[1] JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND
[2] UNIV LEICESTER,DEPT MICROBIOL & IMMUNOL,LEICESTER,LEICS,ENGLAND
来源
TISSUE ANTIGENS | 1995年 / 46卷 / 05期
关键词
allele-specific amplification; histocompatibility testing; HLA class I; HLA class II; DNA typing; PGR-ARMS; PCR-SSP; transplantation;
D O I
10.1111/j.1399-0039.1995.tb03127.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have developed a single DNA typing method which uses 144 sequence-specific primer (SSP) reactions to simultaneously detect all known HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 specificities in an allele specific or group specific manner using the same method, reagents, PCR parameters and protocols for all loci. The results from this integrated class I & II method can be visualized on a single photographic or electronic image and hence is described as ''Phototyping''. Phototyping has an overall resolution greater than or equivalent to good serology and results can be obtained in under 3 hours making the method suitable for genotyping potential cadaver donor peripheral blood without serological backup. This in turn produces the potential for reducing cold ischaemia times in renal transplantation as well as the application of prospective matching to cardiac and liver transplantation. The method has capacity to detect new alleles, for example, novel amplification patterns suggestive of 4 new HLA-B alleles have been detected. The Phototyping set has been used as the sole method of HLA typing for over 1010 individuals. Phototyping is not problem-free; deviations from the standard protocol, poor quality DNA and unsuitable PCR machines can result in individual PCR failures or in incorrect assignment of antigens. Approximately 5% of genotypes were repeated (either partially or fully) because of incomplete or equivocal results.
引用
收藏
页码:355 / 367
页数:13
相关论文
共 27 条
[1]   HLA CLASS-I NUCLEOTIDE-SEQUENCES, 1995 [J].
ARNETT, KL ;
PERHAM, P .
TISSUE ANTIGENS, 1995, 46 (3-2) :217-257
[2]   RAPID HLA-DRB1 GENOTYPING BY NESTED PCR-AMPLIFICATION [J].
BEIN, G ;
GLASER, R ;
KIRCHNER, H .
TISSUE ANTIGENS, 1992, 39 (02) :68-73
[3]   A DNA-RFLP TYPING SYSTEM THAT POSITIVELY IDENTIFIES SEROLOGICALLY WELL-DEFINED AND ILL-DEFINED HLA-DR AND DQ ALLELES, INCLUDING DRW10 [J].
BIDWELL, JL ;
BIDWELL, EA ;
SAVAGE, DA ;
MIDDLETON, D ;
KLOUDA, PT ;
BRADLEY, BA .
TRANSPLANTATION, 1988, 45 (03) :640-646
[4]  
BODMER JG, 1995, TISSUE ANTIGENS, V46, P1
[5]   TISSUE TYPING THE HLA-A LOCUS FROM GENOMIC DNA BY SEQUENCE-SPECIFIC PCR - COMPARISON OF HLA GENOTYPE AND SURFACE EXPRESSION ON COLORECTAL TUMOR-CELL LINES [J].
BROWNING, MJ ;
KRAUSA, P ;
ROWAN, A ;
BICKNELL, DC ;
BODMER, JG ;
BODMER, WF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :2842-2845
[6]   IMPROVEMENTS IN HLA-C TYPING USING SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) INCLUDING DEFINITION OF HLA-CW9 AND CW10 AND A NEW ALLELE HLA-CW7/8V [J].
BUNCE, M ;
BARNARDO, MCNM ;
WELSH, KI .
TISSUE ANTIGENS, 1994, 44 (03) :200-203
[7]   COMPREHENSIVE, SEROLOGICALLY EQUIVALENT DNA TYPING FOR HLA-B BY PCR USING SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) [J].
BUNCE, M ;
FANNING, GC ;
WELSH, KI .
TISSUE ANTIGENS, 1995, 45 (02) :81-90
[8]   RAPID DNA TYPING FOR HLA-C USING SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) - IDENTIFICATION OF SEROLOGICAL AND NON-SEROLOGICALLY DEFINED HLA-C ALLELES INCLUDING SEVERAL NEW ALLELES [J].
BUNCE, M ;
WELSH, KI .
TISSUE ANTIGENS, 1994, 43 (01) :7-17
[9]   RAPID HLA-DQB TYPING BY 8 POLYMERASE CHAIN-REACTION AMPLIFICATIONS WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) [J].
BUNCE, M ;
TAYLOR, CJ ;
WELSH, KI .
HUMAN IMMUNOLOGY, 1993, 37 (04) :201-206
[10]   A NEW SIMPLIFIED METHOD OF GENE TYPING [J].
CHIA, D ;
TERASAKI, P ;
CHAN, H ;
ACALINOVICH, A ;
MARUYA, E ;
SAJI, H ;
WARE, K .
TISSUE ANTIGENS, 1994, 44 (05) :300-305